Inventor · disambiguated record
Peter J. Facchini
Also filed as: FACCHINI PETER J · FACCHINI PETER JAMES
37 granted patents·15 pending applications·20 citations·filing 2001–2024
95Inventor score
Top patents by PatentIndex Score
52 records- 0193US11707447B1C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jul 25, 2023·4 cites·13 claims
- 0290US11142780B2Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereofANTHEIA INC·Filed 2017·Granted Oct 12, 2021·5 cites·16 claims
- 0386US12138276B2Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Granted Nov 12, 2024·0 cites·29 claims
- 0484US10190141B2Compositions and methods for making (R)-Reticuline and precursors thereofEPIMERON INC·Filed 2014·Granted Jan 29, 2019·7 cites·15 claims
- 0583US12128058B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Oct 29, 2024·0 cites·28 claims
- 0683US11479586B2Polynucleotides and polypeptides useful for making alkaloid compoundsANTHEIA INC·Filed 2017·Granted Oct 25, 2022·2 cites·11 claims
- 0782US12133856B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Nov 5, 2024·0 cites·28 claims
- 0882US11945778B2C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Apr 2, 2024·0 cites·23 claims
- 0982US10119155B2Compositions and methods for making (S)-norcoclaurine and (S)-norlaudanosoline, and synthesis intermediates thereofEPIMERON INC·Filed 2015·Granted Nov 6, 2018·2 cites·12 claims
- 1082US2025057861A1Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 1181US12378195B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Aug 5, 2025·0 cites·26 claims
- 1281US2025025483A1Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 1380US12077498B2C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Sep 3, 2024·0 cites·16 claims
- 1479US11918594B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 5, 2024·0 cites·30 claims
- 1579US11845726B2C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Dec 19, 2023·0 cites·16 claims
- 1678US2025100967A1Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 1777US11998557B2Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jun 4, 2024·0 cites·22 claims
- 1876US12338231B1N-heterocycle substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Granted Jun 24, 2025·0 cites·29 claims
- 1976US12173035B2Polynucleotides and polypeptides useful for making alkaloid compoundsANTHEIA INC·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 2076US12065404B2C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Aug 20, 2024·0 cites·15 claims
- 2176US11746087B1C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Sep 5, 2023·0 cites·28 claims
- 2275US12492179B2Substituted ethylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Dec 9, 2025·0 cites·3 claims
- 2375US12358885B2Substituted n-propylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Jul 15, 2025·0 cites·12 claims
- 2475US12195439B1C1-substituted isopropylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Jan 14, 2025·0 cites·21 claims
- 2574US12187679B2Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 7, 2025·0 cites·26 claims
- 2674US11858895B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 2, 2024·0 cites·28 claims
- 2773US2024002894A1Compositions and methods for making (r)-reticuline and precursors thereofANTHEIA INC·Filed 2023·Application pending·0 cites
- 2872US12416029B2Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereofANTHEIA INC·Filed 2021·Granted Sep 16, 2025·0 cites·6 claims
- 2972US2025129036A1C1-substituted isopropylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 3071US2023357810A1Neopinone isomerase and methods of usingANTHEIA INC·Filed 2022·Application pending·0 cites
- 3168US11891360B2Glycosylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Feb 6, 2024·0 cites·26 claims
- 3268US11891359B2Prenylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Feb 6, 2024·0 cites·12 claims
- 3368US11752130B2Carboxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Sep 12, 2023·0 cites·17 claims
- 3468US2025352512A2C4-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Application pending·0 cites
- 3566US10662453B2Compositions and methods for making (S)-norcoclaurine and (S)-norlaudanosoline, and synthesis intermediates thereofWILLOW BIOSCIENCES INC·Filed 2018·Granted May 26, 2020·0 cites·10 claims
- 3665US11613770B2Compositions and methods for making (R)-reticuline and precursors thereofANTHEIA INC·Filed 2018·Granted Mar 28, 2023·0 cites·10 claims
- 3764US11845727B2Aldehyde and ketone derivatives of psilocybin and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Dec 19, 2023·0 cites·18 claims
- 3862US11931338B2Nitrilated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 19, 2024·0 cites·23 claims
- 3961US12428408B2Fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Sep 30, 2025·0 cites·19 claims
- 4061US11560578B2Neopinone isomerase and methods of usingANTHEIA INC·Filed 2018·Granted Jan 24, 2023·0 cites·10 claims
- 4160US2021198706A1Methods For Making and Using Polynucleotide Sequences in the Synthesis of Alkaloid CompoundsEPIMERON INC·Filed 2019·Application pending·0 cites
- 4259US2023040398A1Nitrated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 4357US2025206701A1C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 4457US2019152981A1Compositions and Methods For Making Alkaloid MorphinansEPIMERON INC·Filed 2019·Application pending·0 cites
- 4555US2025197351A1C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 4654US10487345B2Methods for making and using polynucleotide sequences in the synthesis of alkaloid compoundsEPIMERON INC·Filed 2015·Granted Nov 26, 2019·0 cites·12 claims
- 4753US10793885B2Compositions and methods for making noscapine and synthesis intermediates thereofWILLOW BIOSCIENCES INC·Filed 2014·Granted Oct 6, 2020·0 cites·14 claims
- 4852US10227353B2Compositions and methods for making alkaloid morphinansEPIMERON INC·Filed 2015·Granted Mar 12, 2019·0 cites·6 claims
- 4952US2021155963A1Compositions and methods for making noscapine and synthesis intermediates thereofWILLOW BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 5043US2002079846A1Novel glutathione-S-transferase nucleic acids and polypeptides and methods of use thereofFiled 2001·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →